Quinine

BreastfeedingPediatric
  • TRADE NAMES: Adaquin; Chinine; Formula-Q; Genin; M-KYA; Q-Vel; Qualaquin (URL Pharma); Quinoctal; Quinsan; Quinsul; Quiphile
  • INDICATIONS: Malaria
  • CLASS: Antimalarial, Antiprotozoal
  • HALF-LIFE: 8–14 hours

Qualaquin (quinine sulfate) is not idicated for the prevention or treatment of nocturnal leg cramps.

Contra-indicated in patients with prolongation of QT interval, G6PD deficiency, myasthenia gravis, or optic neuritis.

Our database has 65 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
NAILS
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
ENDOCRINE/METABOLIC
GASTROINTESTINAL/HEPATIC
HEMATOLOGIC
NEUROMUSCULAR/SKELETAL
OCULAR
OTIC
RENAL
RESPIRATORY
OTHER


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric